Public Release: 31-May-2015 Immunotherapy drug improves survival for common form of lung cancer Johns Hopkins Medicine In a head-to-head clinical trial comparing standard chemotherapy with the immunotherapy drug nivolumab, researchers found that people…

… that people with squamous-non-small cell lung cancer who received nivolumab lived, on … to treat such patients whose lung cancer progressed, despite standard chemotherapy. Brahmer … with advanced, squamous non-small cell lung cancer whose disease had progressed despite …